168 related articles for article (PubMed ID: 27542736)
1. WSB1: from homeostasis to hypoxia.
Haque M; Kendal JK; MacIsaac RM; Demetrick DJ
J Biomed Sci; 2016 Aug; 23(1):61. PubMed ID: 27542736
[TBL] [Abstract][Full Text] [Related]
2. Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.
Nucifora FC; Nucifora LG; Ng CH; Arbez N; Guo Y; Roby E; Shani V; Engelender S; Wei D; Wang XF; Li T; Moore DJ; Pletnikova O; Troncoso JC; Sawa A; Dawson TM; Smith W; Lim KL; Ross CA
Nat Commun; 2016 Jun; 7():11792. PubMed ID: 27273569
[TBL] [Abstract][Full Text] [Related]
3. WSB1 promotes tumor metastasis by inducing pVHL degradation.
Kim JJ; Lee SB; Jang J; Yi SY; Kim SH; Han SA; Lee JM; Tong SY; Vincelette ND; Gao B; Yin P; Evans D; Choi DW; Qin B; Liu T; Zhang H; Deng M; Jen J; Zhang J; Wang L; Lou Z
Genes Dev; 2015 Nov; 29(21):2244-57. PubMed ID: 26545811
[TBL] [Abstract][Full Text] [Related]
4. WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation.
Kim JJ; Lee SB; Yi SY; Han SA; Kim SH; Lee JM; Tong SY; Yin P; Gao B; Zhang J; Lou Z
Cell Res; 2017 Feb; 27(2):274-293. PubMed ID: 27958289
[TBL] [Abstract][Full Text] [Related]
5. WSB1 regulates c-Myc expression through
Gao X; You J; Gong Y; Yuan M; Zhu H; Fang L; Zhu H; Ying M; He Q; Yang B; Cao J
Acta Pharm Sin B; 2022 Mar; 12(3):1225-1239. PubMed ID: 35530152
[TBL] [Abstract][Full Text] [Related]
6. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha.
Baek JH; Mahon PC; Oh J; Kelly B; Krishnamachary B; Pearson M; Chan DA; Giaccia AJ; Semenza GL
Mol Cell; 2005 Feb; 17(4):503-12. PubMed ID: 15721254
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells.
Cao J; Wang Y; Dong R; Lin G; Zhang N; Wang J; Lin N; Gu Y; Ding L; Ying M; He Q; Yang B
Cancer Res; 2015 Nov; 75(22):4839-51. PubMed ID: 26424695
[TBL] [Abstract][Full Text] [Related]
8. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
Lewis MD; Roberts BJ
Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
[TBL] [Abstract][Full Text] [Related]
9. DUBs, Hypoxia, and Cancer.
Mennerich D; Kubaichuk K; Kietzmann T
Trends Cancer; 2019 Oct; 5(10):632-653. PubMed ID: 31706510
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.
Zimmer M; Doucette D; Siddiqui N; Iliopoulos O
Mol Cancer Res; 2004 Feb; 2(2):89-95. PubMed ID: 14985465
[TBL] [Abstract][Full Text] [Related]
11. From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response.
Calzado MA; De La Vega L; Munoz E; Schmitz ML
Cell Cycle; 2009 Jun; 8(11):1659-64. PubMed ID: 19448429
[TBL] [Abstract][Full Text] [Related]
12. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation.
Moehlenbrink J; Bitomsky N; Hofmann TG
Cancer Lett; 2010 Jun; 292(1):119-24. PubMed ID: 20018442
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA; Ohh M
Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
[TBL] [Abstract][Full Text] [Related]
15. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
17. WSB1, a Hypoxia-Inducible E3 Ligase, Promotes Myofibroblast Accumulation and Attenuates Alveolar Epithelial Regeneration in Mouse Lung Fibrosis.
Chong L; Zou L; Xiang L; Song X; Miao W; Yan X; Xu M; Ling G; El Agha E; Bellusci S; Lou Z; Zhang H; Zhang JS
Am J Pathol; 2024 May; 194(5):656-672. PubMed ID: 38325552
[TBL] [Abstract][Full Text] [Related]
18. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL
Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178
[TBL] [Abstract][Full Text] [Related]
20. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
